Aarti Asnani

Dr. Aarti Asnani

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2025 in European Heart Journal
Verified
Journal Article
Closed access
JPJohn R Power
John R Power
CDCharles Dolladille
Charles Dolladille
BOBenay Ozbay
Benay Ozbay
Adrien ProcureurAdrien Procureur
Adrien Procureur
SEStephane Ederhy
Stephane Ederhy
IRInternational ICI-Myocarditis Registry
International ICI-Myocarditis Registry
Background and Aims: Immune checkpoint inhibitors (ICI) are associated with life-threatening myocarditis but milder presentations are increasingly recognized. The same autoimmune process that causes ICI myocarditis can manifest concurrent generalized myositis, myasthenia-like syndrome, and respiratory muscle failure. Prognostic factors for this ‘cardiomyotoxicity’ are lacking. The main aim of this study was to determine predictors and construct a risk score associated with negative outcomes in patients admitted for ICI myocarditis. Methods: A multicentre registry collected data retrospectively from 17 countries between 2014 and 2023. A multivariable Cox regression model was used to determine risk factors for the primary composite outcome: time to severe arrhythmia, heart failure, respiratory muscle failure, and/or cardiomyotoxicity-related death. Covariates included demographics, comorbidities, cardiomuscular symptoms, diagnostics, and treatments. Time-dependent covariates were used, and missing data were imputed. A point-based prognostic risk score was derived and externally validated. Results: In 748 patients (67% male, age 23–94 years), 30-day incidence of the primary composite outcome, cardiomyotoxic death, and overall death were 33%, 13%, and 17%, respectively. By multivariable analysis, the primary composite outcome was associated with active thymoma (hazard ratio [HR] 3.6, 95% confidence interval [CI] 1.7–7.7), presence of cardiomuscular symptoms (HR 2.6 [1.5–4.2]), low QRS voltage on presenting electrocardiogram (HR for ≤0.5 mV vs >1 mV 1.9 [1.1–3.1]), left ventricular ejection fraction (LVEF) < 50% (HR 1.7 [1.1–2.6]), and incremental troponin elevation (HR 1.8 [1.4–2.4], 2.9 [1.8–4.7], and 4.6 [2.3–9.3], for 20, 200, and 2000-fold above upper reference limit, respectively). A prognostic risk score developed using these parameters showed good performance; 30-day primary outcome incidence increased gradually from 4% (risk score = 0) to 81% (risk score ≥ 4). This risk score was externally validated in two independent French and US cohorts. This risk score was used prospectively in the external French cohort to identify low-risk patients who were managed with no immunosuppression resulting in no cardiomyotoxic events. Conclusions: ICI-associated myocarditis can manifest with high morbidity and mortality. Myocarditis severity is associated with magnitude of troponin, thymoma, low QRS voltage, depressed LVEF, and cardiomuscular symptoms. A risk score incorporating these features performed well. Clinical trial registration: NCT04294771 and NCT05454527.

11 April 2018 in Current Oncology Reports
Verified
Journal Article
Closed access
PDF file
AAAarti Asnani
Aarti Asnani

1 November 2019 in Cardiology Clinics
Verified
Journal Article
Closed access
JKJaya Kanduri
Jaya Kanduri
LMLuis Alberto More
Luis Alberto More
AGAnuradha Godishala
Anuradha Godishala
AAAarti Asnani
Aarti Asnani

3 February 2021 in Current Cardiology Reports
Verified
Journal Article
Closed access
PDF file
LMLuis Alberto More
Luis Alberto More
SLSarah Lane
Sarah Lane
AAAarti Asnani
Aarti Asnani

5 July 2019 in Journal of Cardiovascular Translational Research
Verified
Journal Article
Closed access
PDF file
AAAarti Asnani
Aarti Asnani
XSXu Shi
Xu Shi
LFLaurie Farrell
Laurie Farrell
RLRahul Lall
Rahul Lall
ISIgal A. Sebag
Igal A. Sebag
MSMarielle Scherrer-Crosbie
Marielle Scherrer-Crosbie

1 July 2018 in Current Problems in Cancer
Verified
Journal Article
Closed access
SYShu Yang
Shu Yang
AAAarti Asnani
Aarti Asnani